Press and Business Intelligence in Attendance at BioTrinity 2014

As well as being a great conference to partner, BioTrinity 2014 will be an opportunity to raise your profile in print and online by meeting journalists from trade press including:

SCRIP (Informa), BioCentury, Bloomberg, EP Vantage, Nature Biotechnology, Clinica, Financial Times, Wall Street Journal, In Vivo, MedNous, Mergermarket, Pharmalicensing, Innovations in Pharmaceutical Technology (Samedan), Pharmafocus, Pink Sheet, BioPharm Insight, Chemistry World, Pf Discovery, Pharma Letter, BioTechPanel Inc, PharmaVentures, PharmaWire, pharmaphorum, R&D Focus, IMS Health, Drug Discovery Today, International Clinical Trials, International Labmate, PharmaTV and Current Partnering.

Press and Arranging Press Passes

All media relations for BioTrinity, including press registration, is coordinated by Citigate Dewe Rogerson, OBN’s media sponsor.

BioTrinity welcomes all journalists free of charge, particularly those writing for industry-specific news and publishing organisations.

In order to receive a Press Pass, journalists must contact Citigate Dewe Rogerson and will need to provide valid press credentials. The press pass will provide journalists with full access to BioTrinity including the partnering software to enable you to make meeting requests in advance of the conference.

For all media enquiries and to register as a journalist for BioTrinity contact Janine Hagan at Citigate Dewe Rogerson with your full contact details (including job title):

Janine Hagan
Citigate Dewe Rogerson
T: 020 7282 1068

If you have any general questions regarding the event, please contact Jenny Hazelden

Please note that pre-registration is essential to gain entry to the conference. No badge - no entry! 

Press Area

A dedicated Press Area will be located within the main Exhibition Hall. The Press Area, managed by Citigate, will be equipped with a PC and a printer and free wifi access will also be available. We encourage all attending companies to display their Press Releases in the Press Area.


BioTrinity 2013 highlights
877 delegates from 28 countries
520 companies
168 speakers
86 company presentations
1679 scheduled one-to-one meetings
97 investors from 11 countries
66 exhibitors
32 global pharma/corporate venture